Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Nov 23, 2010 shooter eric m Director Automatic Sell 7,500 30.00
Sep 9, 2011 goldberg murray a Officer Automatic Sell 7,542 67.19 - 69.08
Mar 30, 2011 stahl neil Officer Automatic Sell 7,692 45.00
Mar 30, 2011 stahl neil Officer Option Execute 7,692 13.00
Sep 18, 2012 powchik peter Officer Automatic Sell 7,823 148.78
Jan 16, 2013 goldberg murray a Officer Automatic Sell 7,878 170.57 - 174.56
Sep 6, 2011 schleifer leonard s Officer Automatic Sell 7,900 63.01 - 68.42
Apr 12, 2010 vagelos p roy Director Disposition (Non Open Market) 7,952 n/a
Jul 25, 2012 powchik peter Officer Automatic Sell 7,981 126.76
Dec 21, 2009 gilman alfred g Director Disposition (Non Open Market) 8,000 n/a
Aug 13, 2014 vagelos p roy Officer Sell 8,028 340.01
Oct 4, 2010 vagelos p roy Director Disposition (Non Open Market) 8,035 n/a
Jul 15, 2010 roberts william Officer Acquisition (Non Open Market) 8,041 n/a
Jul 9, 2008 vagelos p roy Director Disposition (Non Open Market) 8,105 n/a
Aug 28, 2008 roberts william Officer Acquisition (Non Open Market) 8,106 n/a
Aug 28, 2008 vagelos p roy Director Disposition (Non Open Market) 8,106 n/a
Nov 13, 2012 goldberg murray a Officer Option Execute 8,176 8.50 - 65.76
Nov 26, 2013 shooter eric m Director Acquisition (Non Open Market) 8,185 n/a
Nov 26, 2013 shooter eric m Director Disposition (Non Open Market) 8,185 n/a
Aug 6, 2014 van plew daniel p Officer Disposition (Non Open Market) 8,194 336.11
Showing 341-360 of 837 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)